Michael Fisher, MD

Michael Fisher, MD, is an attending physician at CHOP’s Cancer Center with a special interest in brain tumors and neurofibromatosis.

Areas of Expertise: Brain tumor survivorship, Imaging of plexiform neurofibromas and brain tumors, Management of brain tumors, Neurofibromatosis (NF) and NF-related tumors
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

  • Education and Training

    Medical School

    Harvard Medical School (MD), Cambridge, Mass.

    Internship

    Children's Hospital Boston, Mass.

    Residency

    Children's Hospital Boston, Mass.

    Fellowship

    The Children's Hospital of Philadelphia, Philadelphia, Pa., Hematology/Oncology The Children's Hospital of Philadelphia, Philadelphia, Pa., Neuro-Oncology

    Board Certification

    American Board of Pediatrics
    American Board of Pediatrics/Pediatric Hematology-Oncology

    Undergraduate Degree

    Amherst College, Amherst, Mass., BA, Psychology

  • Titles and Academic Titles

    Attending physician

    Associate professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

  • Conditions Treated
  • Centers and Programs
  • Publications

    Books

    Chapters

    2010

    Fisher MJ, Rheingold SR. Oncologic emergencies. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 6th ed. Philadelphia: Lippincott, William & Wilkins; 2010.

    2008

    Fisher MJ, Minturn J, Armstrong G, Phillips PC. Brain tumors. In: Brodeur GM, Manno CS, editors. Requisites in pediatrics: hematology and oncology. Philadelphia: Elsevier Mosby; 2008.

    Fisher MJ. Brain tumors. In: Schwartz MW, editor. The 5-minute pediatric consult. 5th ed. Philadelphia: Lippincott William & Wilkins; 2008. p. 120-21.

    2006

    Fisher MJ, Phillips PC. PET imaging of brain tumors. In: Charron M, editor. Practical pediatric PET imaging. New York: Springer Science + Business Media, Inc.; 2006. p. 175-219.

    2005

    Fisher MJ. Brain tumors. In: Schwartz MW, editor. The 5-minute pediatric consult. 4th ed. Philadelphia: Lippincott William & Wilkins; 2005. p. 194-95.

    2004

    Fisher MJ, Marino BS, Litman RS. Oncological diseases. In: Litman RS, editor. Pediatric anesthesia: the requisites in anesthesiology. Philadelphia: Elsevier Mosby; 2004. p. 60-7.

    2003

    Fisher MJ, Kramer DL, Needle M. Brain tumors. In: Schwartz MW, editor. The 5-minute pediatric consult. 3rd ed. Baltimore: Willian and Wilkins; 2003. p. 190-91.

    2001

    Fisher MJ, Cohen A. Normal red blood cell indices and differential diagnosis of anemia. In: Polin RA, Spitzer A, editors. Fetal and neonatal secrets. Philadelphia: Hanley and Belfus, Inc.; 2001. p. 227-29.

    Abstracts

    2009

    Fisher MJ. Photodynamic therapy in children with NF1 and plexiform neurofibromas [abstract].  2009 Children’s Tumor Foundation Neurofibromatosis Conference. 2009; Portland, OR. p.35.

    Fisher MJ, Balcer L, Listernick R, Gutmann D, Packer R, Ferner R, et al. Retrospective analysis of NF1-associated optic glioma visual outcomes [abstract]. 2009 Children’s Tumor Foundation Neurofibromatosis Conference. 2009, Portland, OR. p.89.

    Campen CJ, Fisher MJ, Belasco JB, Ichord RN. Moyamoya disease and neurofibromatosis  type 1 in children: a prospective cohort study [abstract]. International Stroke Conference. 2009. San Diego.

    Papers

    2011

    Avery RA, Liu GT, Fisher MJ, Quinn GE, Belasco JB, Phillips PC, et al. Retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol. 2011 Mar;151(3):542-9.e2. Epub 2011 Jan 12. Cited in PubMed: PMID 21232732. Read the abstract

    2010

    Palmer SL, Hassall T, Evankovich K, Mabbott DJ, Bonner M, Deluca C, et al. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neuro Oncol. 2010 Dec 12(12):1311-7. Epub 2010 Aug 16.Cited in PubMed: PMID 20713408. Read abstract.

    2009

    Sievert AJ, Fisher MJ. Pediatric low-grade gliomas. J Child Neurol. 2009 Nov;24(11):1397-408. Cited in PubMed: PMID 19841428. Read the article

    Packer RJ, Jakacki R, Horn M, Rood B, Vezina G, MacDonald T, et al. Objective response of multiply recurrent pediatric low-grade gliomas to bevacizumab and irinotecan. Pediatric Blood & Cancer, 52:791–795, 2009. Cited in PubMed: PMID 19165892. Read the abstract

    Chi SN, Zimmerman MA, Yao X, Fletcher W, Cohen K, Burger P, et al.   Intensive multi-modality treatment for children with newly diagnosed  CNS atypical teratoid rhabdoid tumor. J Clin Oncol, 27(3):385-9, 2009. Epub 2008 Dec 8. Cited in PubMed: PMID 19064966. Read the article

    Posters and Presentations

    2010

    Fisher MJ. NF1 and optic pathway gliomas: an update [presentation]. University Children's Hospital Ljubljana; 2010 Jun 24; Ljubljana, Slovenia.

    Fisher MJ. Phase II study of the mTOR inhibitor sirolimus for non-progressive NF1-associated plexiform neurofibromas: a Neurofibromatosis Consortium study [presentation]. 14th International Symposium on Pediatric Neuro-Oncology; 2010 Jun 23; Vienna, Austria.

    Fisher MJ. Neurofibromatosis type 1 associated optic glioma visual outcomes following chemotherapy: a multi-center retrospective analysis [presentation]. 2010 Children's Tumor Foundation NF Conference; 2010 Jun 7; Baltimore, MD.

    Fisher MJ. Resolved: all NF1 patients should not have whole body MRI to assess the burden of disease at time of diagnosis [presentation]. 2010 Children's Tumor Foundation NF Conference; 2010 Jun 6; Baltimore, MD.

    Fisher MJ. A phase II study of the mTOR inhibitor sirolimus for NF1-associated plexiform neurofibromatomas: a Neurofibromatosis Consortium study [presentation]. 2010 Children's Tumor Foundation NF Conference; 2010 Jun 5; Baltimore, MD.

    Fisher MJ. Other clinical trials for NF1 [presentation]. 2010 NF Family Conference; 2010 Apr 17; Cincinnati, OH.

    Fisher MJ. Clinical trials for plexiform neurofibromatosis [presentation]. 2010 NF Family Conference; 2010 Apr 17; Cincinnati, OH.

    Fisher MJ. NF1 and optic pathways gliomas: an update [oncology grand rounds]. Cincinnati Children's Hospital Medical Center; 2010 Apr 16; Cincinnati, OH.

    Fisher MJ. Neurofibromatosis type 1 associated optic glioma visual outcomes following chemotherapy: a multi-center retrospective analysis [presentation]. 36th Annual North American Neuro-Ophthalmology Society Meeting; 2010 Mar 8; Tuscon, AZ.

    Fisher MJ. Brain tumor 101 [presentation]. Pediatric Brain Tumor Consortium Meeting; 2010 Feb 28; Alexandria, VA.

    2009

    Fisher MJ. New imaging modalities and treatment approaches for plexiform neurofibromas [presentation]. Shanghai Children's Medical Center; 2009 Nov 6; Shanghai, China.

    Fisher MJ. Plexiform neurofibromas: new approaches to management [presentation]. Beijing Children's Hospital; 2009 Nov 3; Beijing, China.

    Fisher MJ. Photodynamic therapy in children with NF1 and plexiform neurofibromas [presentation]. 2009 Children's Tumor Foundation NF Conference; 2009 Jun 14; Portland, OR.

    Fisher MJ. Vinblastine/methotrexate for plexiform neurofibromas: a phase II study [presentation]. Neurofibromatosis Consortium Meeting; 2009 Jun 13; Portland, OR.

    Fisher MJ. Phase I trial of photodynamic therapy (PDT) using intratumoral delivery of non-coherent light for photoactivation of LS11 in children with plexiform neurofibromas [presentation]. Neurofibromatosis Consortium Meeting; 2009 Jun 13; Portland, OR.

     

  • Editorial and Academic Positions

    Editorial positions

    Reviewer

    Pediatric Blood & Cancer
    Libertas Academica